Emerald Mutual Fund Advisers Trust Curis Inc Transaction History

Emerald Mutual Fund Advisers Trust

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$0.71 - $2.43 $1.3 Million - $4.45 Million	-1,830,273 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$2.31 - $5.13 $386,777 - $858,946	-167,436 Reduced 8.38%	1,830,273 $4.36 Million
Q4 2021 Feb 02, 2022	BUY	$4.45 - $8.09 $89,000 - $161,800	20,000 Added 1.01%	1,997,709 $9.51 Million
Q3 2021 Oct 28, 2021	SELL	$6.94 - $8.85 $413,776 - $527,654	-59,622 Reduced 2.93%	1,977,709 $15.5 Million
Q2 2021 Jul 29, 2021	BUY	$7.45 - $16.27 $1.05 Million - $2.3 Million	141,602 Added 7.47%	2,037,331 $16.4 Million
Q1 2021 Apr 29, 2021	BUY	$8.78 - $12.8 $4.39 Million - $6.4 Million	499,636 Added 35.79%	1,895,729 $21.5 Million
Q4 2020 Jan 29, 2021	BUY	$1.08 - $8.2 $1.51 Million - $11.4 Million	1,396,093 New	1,396,093 $11.4 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.